Identifying the Potential Substrates of the Depalmitoylation Enzyme Acyl-protein Thioesterase 1

Author(s): Huicong Liu, Peipei Yan, Junyan Ren, Can Wu, Wei Yuan, Muding Rao, Zhongjian Zhang*, Eryan Kong*.

Journal Name: Current Molecular Medicine

Volume 19 , Issue 5 , 2019

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer

Abstract:

Background: The homeostasis of palmitoylation and depalmitoylation is involved in various cellular processes, the disruption of which induces severe physiological consequences. Acyl-protein thioesterase (APT) and palmitoyl-protein thioesterases (PPT) catalyze the depalmitoylation process. The natural mutation in human PPT1 caused neurodegenerative disease, yet the understanding of APT1 remains to be elucidated. While the deletion of APT1 in mice turned out to be potentially embryonically lethal, the decoding of its function strictly relied on the identification of its substrates.

Objective: To determine the potential substrates of APT1 by using the generated human APT1 knockout cell line.

Methods : The combined techniques of palmitoyl-protein enrichment and massspectrometry were used to analyze the different proteins. Palmitoyl-proteins both in HEK293T and APT1-KO cells were extracted by resin-assisted capture (RAC) and data independent acquisition (DIA) quantitative method of proteomics for data collection.

Results: In total, 382 proteins were identified. The gene ontology classification segregated these proteins into diverse biological pathways e.g. endoplasmic reticulum process and ubiquitin-mediated proteolysis. A few potential substrates were selected for verification; indeed, major proteins were palmitoylated. Importantly, their levels of palmitoylation were clearly changed in APT1-KO cells. Interestingly, the proliferation of APT1-KO cells escalated dramatically as compared to that of the WT cells, which could be rescued by APT1 overexpression.

Conclusion: Our study provides a large scale of potential substrates of APT1, thus facilitating the understanding of its intervened molecular functions.

Keywords: APT1, palmitoylation, potential substrates, mass spectrometry, data-independent acquisition, proliferation.

[1]
Nadolski MJ, Linder ME. Protein lipidation. FEBS J 2007; 274(20): 5202-10.
[2]
Kohlschutter A, Schulz A. Towards understanding the neuronal ceroid lipofuscinoses. Brain Dev 2009; 31(7): 499-502.
[3]
Sima N, Li R, Huang W, et al. Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1/PPT1) and late infantile (CLN2/TPP1) neuronal ceroid lipofuscinoses. Orphanet J Rare Dis 2018; 13(1): 54.
[4]
Ozono T, Kinoshita M, Narita A, et al. Juvenile-onset neuronal ceroid lipofuscinosis (CLN1) disease with a novel deletion and duplication in the PPT1 gene. J Neurol Sci 2018; 388: 4-6.
[5]
Wisniewski KE, Gordonmajszak W, Maslinski S, et al. Altered protein patterns in brains of children with neuronal ceroid lipofuscinosis. Am J Med Genet 1992; 42(4): 568-74.
[6]
Benjannet S, Elagoz A, Wickham L, et al. Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J Biol Chem 2001; 276(14): 10879-87.
[7]
Koegl M, Zlatkine P, Ley SC, et al. Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif. Biochem J 1994. 303 ( Pt 3)(3): 749-53.
[8]
Wang J, Shan C, Cao W, et al. SCG10 promotes non-amyloidogenic processing of amyloid precursor protein by facilitating its trafficking to the cell surface. Hum Mol Genet 2013; 22(24): 4888-900.
[9]
Butland SL, Sanders SS, Schmidt ME, et al. The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington’s disease. Hum Mol Genet 2014; 23(15): 4142-60.
[10]
Rocks O, Peyker A, Kahms M, et al. An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science 2005; 307(5716): 1746-52.
[11]
Schmick M, Kraemer A, Bastiaens PI. Ras moves to stay in place. Trends Cell Biol 2015; 25(4): 190-7.
[12]
Won SJ, Cheung See Kit M, Martin BR. Protein depalmitoylases. Crit Rev Biochem Mol Biol 2018; 53(1): 83-98.
[13]
Duncan, Gilman AG. A cytoplasmic acyl-protein thioesterase that removes palmitate from G protein alpha subunits and p21(RAS). J Biol Chem 1998; 273(25): 15830-7.
[14]
Kong E, Peng S, Chandra G, et al. Dynamic palmitoylation links cytosol-membrane shuttling of acyl-protein thioesterase-1 and acyl-protein thioesterase-2 with that of proto-oncogene H-Ras product and growth-associated protein-43. J Biol Chem 2013; 288(13): 9112-25.
[15]
Zeidman R, Jackson CS, Magee AI. Protein acyl thioesterases.(Review) Mol Membr Biol 2009; 26(1): 32-41.
[16]
Forrester MT, Hess DT, Thompson JW, et al. Site-specific analysis of protein S-acylation by resin-assisted capture. J Lipid Res 2011; 52(2): 393-8.
[17]
Dowal L, Yang W, Freeman MR, et al. Proteomic analysis of palmitoylated platelet proteins. Blood 2011; 118(13): e62-73.
[18]
Edmonds MJ, Geary B, Doherty MK, et al. Analysis of the brain palmitoyl-proteome using both acyl-biotin exchange and acyl-resin-assisted capture methods. Sci Rep 2017; 7(1): 3299.
[19]
Nigjeh EN, Chen R, Brand RE, et al. Quantitative Proteomics Based on Optimized Data-independent-acquisition in Plasma Analysis. J Proteome Res 2017; 16(2): 665-76.
[20]
Kim SJ, Zhang Z, Sarkar C, et al. Palmitoyl protein thioesterase-1 deficiency impairs synaptic vesicle recycling at nerve terminals, contributing to neuropathology in humans and mice. Jof Clin Invest 2008; 118(9): 3075-86.
[21]
Sandoval D, Hill S, Ziemba A, et al. Ubiquitin-conjugating enzyme Cdc34 and ubiquitin ligase Skp1-cullin-F-box ligase (SCF) interact through multiple conformations. J Biol Chem 2015; 290(2): 1106-18.
[22]
Rojas F, Koszela J, Búa J, et al. The ubiquitin-conjugating enzyme CDC34 is essential for cytokinesis in contrast to putative subunits of a SCF complex in Trypanosoma brucei. PLoS Negl Trop Dis 2017; 11(6): e0005626.
[23]
Liu X, Zhang Y, Hu Z, et al. The catalytically inactive mutation of the ubiquitin-conjugating enzyme CDC34 affects its stability and cell proliferation. Protein J 2018; 37(2): 132-43.
[24]
Ma X, Zhao J, Yang F, et al. Ubiquitin conjugating enzyme E2 L3 promoted tumor growth of NSCLC through accelerating p27kip1 ubiquitination and degradation. Oncotarget 2017; 8(48): 84193-203.
[25]
Lewis MJ, Vyse S, Shields AM, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet 2015; 96(2): 221-34.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 5
Year: 2019
Page: [364 - 375]
Pages: 12
DOI: 10.2174/1566524019666190325143412
Price: $58

Article Metrics

PDF: 36
HTML: 6
EPUB: 1
PRC: 2